Gemcitabine With Abraxane and Other Investigational Therapies in Neoadjuvant Treatment of Pancreatic Adenocarcinoma
Status:
Completed
Trial end date:
2019-10-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the role of Gemcitabine and Abraxane in the treatment of resectable
and borderline-resectable pancreatic cancer by giving the chemotherapy before surgery.